Storia in 4 fonti

Popular GLP-1 weight-loss drugs linked to lower risks of addiction and overdose

A massive study of more than 600,000 U.S. veterans suggests that popular GLP-1 drugs such as semaglutide may do far more than help with diabetes and weight loss—they could also fight addiction itself. Researchers found that people taking these medications were less likely to develop substance use disorders involving alcohol, nicotine, cannabis, cocaine, opioids, and other drugs, while those already struggling with addiction experienced fewer overdoses, hospitalizations, emergency visits, and drug-related deaths.

Raccontata da

gizmodo.com

scientificamerican.com

hindustantimes.com

sciencedaily.com

Confronto fonti

4 prospettive sulla stessa storia

AI · summaries

sciencedaily.comStai leggendo1 mesi fa

Can Ozempic Treat Alcoholism? Here's What You Should Know

A first Lancet RCT (26 weeks, n=100) found semaglutide reduced alcohol consumption and heavy drinking days vs placebo. The shared dopamine mechanism implies GLP-1s could address multiple addictions, reshaping Novo Nordisk's pipeline beyond obesity.

Leggi questa versione → originale

hindustantimes.com1 mesi fa

Less stress, addiction, brain fog: Ozempic, GLP-1 drugs may be impacting patients' brain, neural networks

GLP-1 drugs may curb addiction and craving, making some patients less likely to drink alcohol. It could ease anxiety, compulsive thinking and emotional distress | World News

Leggi questa versione → originale

scientificamerican.com1 mesi fa

New powerful GLP-1 drugs drop a lot of weight fast. How does that affect health?

New-generation GLP-1 drugs, such as retatrutide, are achieving higher rates of weight loss. How much weight is too much and too fast to lose?

Leggi questa versione → originale

Popular GLP-1 weight-loss drugs linked to lower risks of addiction and overdose

Confronto fonti